Atlas Trials

Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV

Clinical trial NCT03181607 · UNKNOWN

Trial details

NCT number
NCT03181607
Sponsor
Xingfei Pan
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis bWomen
Start date
2017-01-01
Primary completion
2019-05-26
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.